Breast Cancer Clinical Trial
Official title:
Tailoring Surgical Management of Multifocal Breast Cancer:is There a Possibility
Multi-focal Breast Cancers(MFBC) still have undiscoverable Clinical Significance reflecting on a debatable surgical decision for this Category of breast cancer. A prospective study was conducted using certain surgical technique as a surgical treatment for female patients with operable breast cancer managed at the Surgical Oncology Unit, Alexandria University from May. 2017 to May2018 and will be followed for 3 Years.Analysis will be done to settle a paradigm for surgical management of Multi-focal Breast Cancer
- Age at diagnosis: young patients are defined as younger than 35 years.
- Surgical techniques: Preoperatively all patients will undergo physical examination of
both breasts and axillae as well as bilateral mammograms and ultrasonography of both
breasts. Histopathological diagnosis of cancer will be made prior to surgery. The
planned procedure will be discussed. Different oncoplastic techniques will be utilized
to achieve oncologically appropriate margins with either sentinel lymph node detection
or axillary lymph node dissection according to the triple assessment of the patients .
Surgical margins were determined by macroscopic and histologic examination of frozen
sections of the breast specimens in the operating room. An adequate safety margin of 1cm
was always insured. Breast remodeling will be done according to breast size, degree of
ptosis and size of defect.
- Tumor characteristics: size, nodal status, presence of lympho-vascular invasion, amount
of intraductal component, tumor grade, margin status, hormone receptor, and Her2 neu
status.
- Margins will be regarded as negative when permanent histological examination found no
ink on the tumor.
- Postoperative surgical complications will be documented if happened; seroma formation,
hematoma and or wound dehiscence.
- Cosmetic outcome: The postoperative esthetic result will be evaluated asking the
patients to rate the postoperative cosmetic result and their degree of satisfaction
compared to the preoperative breast using a five-point scale (excellent, 5; good, 4;
fair, 3; poor, 2;bad, 1). Objective assessment of the cosmetic result was done by two
surgeons, rated on a visual analog scale from 1 (unacceptable result) to 10 (excellent
result). Evaluation is based on 5 criteria, namely: breast symmetry, glandular tissue
defects, nipple and areola reconstruction, scar quality and/or retraction, and the
resultant breast shape. (14)
- The occurrence of loco-regional recurrence or distant metastases during the follow-up
period was recorded and considered as an end point for follow-up.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Recruiting |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |